Literature DB >> 23995121

Conservative initiation of antimicrobial treatment in ICU patients with suspected ICU-acquired infection: more haste less speed.

Tjasa Hranjec1, Robert G Sawyer.   

Abstract

PURPOSE OF REVIEW: To review the recent literature supporting the idea that in some patients suspected of having a new ICU-acquired infection, antibiotics can be withheld until evidence to confirm diagnosis is obtained. RECENT
FINDINGS: Recent publications demonstrate that in community-acquired pneumonia, severe sepsis presenting to the emergency room, and suspected ICU-acquired infection, the time to antibiotic therapy does not necessarily seem to be a key determinant of outcome.
SUMMARY: In the ICU, patients without septic shock but suspected of having an ICU-acquired infection may be able to have antibiotics withheld until infection is confirmed using a combination of laboratory, radiologic, and microbiological data.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23995121      PMCID: PMC3888949          DOI: 10.1097/MCC.0b013e328364d525

Source DB:  PubMed          Journal:  Curr Opin Crit Care        ISSN: 1070-5295            Impact factor:   3.687


  5 in total

1.  Association between timing of antibiotic administration and mortality from septic shock in patients treated with a quantitative resuscitation protocol.

Authors:  Michael A Puskarich; Stephen Trzeciak; Nathan I Shapiro; Ryan C Arnold; James M Horton; Jonathan R Studnek; Jeffrey A Kline; Alan E Jones
Journal:  Crit Care Med       Date:  2011-09       Impact factor: 7.598

2.  Time to first antibiotics for pneumonia is not associated with in-hospital mortality.

Authors:  Andrew Sucov; Jonathan Valente; Steven E Reinert
Journal:  J Emerg Med       Date:  2013-02-26       Impact factor: 1.484

Review 3.  Delayed antibiotics for respiratory infections.

Authors:  Geoffrey K P Spurling; Chris B Del Mar; Liz Dooley; Ruth Foxlee; Rebecca Farley
Journal:  Cochrane Database Syst Rev       Date:  2013-04-30

4.  Aggressive versus conservative initiation of antimicrobial treatment in critically ill surgical patients with suspected intensive-care-unit-acquired infection: a quasi-experimental, before and after observational cohort study.

Authors:  Tjasa Hranjec; Laura H Rosenberger; Brian Swenson; Rosemarie Metzger; Tanya R Flohr; Amani D Politano; Lin M Riccio; Kimberley A Popovsky; Robert G Sawyer
Journal:  Lancet Infect Dis       Date:  2012-08-28       Impact factor: 25.071

5.  Direct matrix-assisted laser desorption ionization time-of-flight mass spectrometry improves appropriateness of antibiotic treatment of bacteremia.

Authors:  Anne L M Vlek; Marc J M Bonten; C H Edwin Boel
Journal:  PLoS One       Date:  2012-03-16       Impact factor: 3.240

  5 in total
  5 in total

Review 1.  [First-line anti-infective treatment in sepsis].

Authors:  H Burgmann
Journal:  Med Klin Intensivmed Notfmed       Date:  2014-10-26       Impact factor: 0.840

Review 2.  Early Diagnosis of Sepsis: Is an Integrated Omics Approach the Way Forward?

Authors:  Raymond J Langley; Hector R Wong
Journal:  Mol Diagn Ther       Date:  2017-10       Impact factor: 4.074

3.  Integrative "omic" analysis of experimental bacteremia identifies a metabolic signature that distinguishes human sepsis from systemic inflammatory response syndromes.

Authors:  Raymond J Langley; Jennifer L Tipper; Shannon Bruse; Rebecca M Baron; Ephraim L Tsalik; James Huntley; Angela J Rogers; Richard J Jaramillo; Denise O'Donnell; William M Mega; Mignon Keaton; Elizabeth Kensicki; Lee Gazourian; Laura E Fredenburgh; Anthony F Massaro; Ronny M Otero; Vance G Fowler; Emanuel P Rivers; Chris W Woods; Stephen F Kingsmore; Mohan L Sopori; Mark A Perrella; Augustine M K Choi; Kevin S Harrod
Journal:  Am J Respir Crit Care Med       Date:  2014-08-15       Impact factor: 21.405

Review 4.  Diagnostics, therapy and outcome prediction in abdominal sepsis: current standards and future perspectives.

Authors:  A Hecker; F Uhle; T Schwandner; W Padberg; M A Weigand
Journal:  Langenbecks Arch Surg       Date:  2013-11-02       Impact factor: 3.445

5.  Agreement on the prescription of antimicrobial drugs.

Authors:  Eduardo Casaroto; Alexandre R Marra; Thiago Zinsly Sampaio Camargo; Ana Rita Araújo de Souza; Carlos Eduardo Saldanha de Almeida; Elizia Piassi Pedroti; Elivane da Silva Victor; Oscar Fernando Pavão dos Santos; Michael B Edmond; Alexandre Holthausen Campos
Journal:  BMC Infect Dis       Date:  2015-06-30       Impact factor: 3.090

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.